Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials
Conflicto de intereses Eva Vilarrasa ha recibido honorarios por consultora y/o como oradora y/o para viajes y/o ha participado en ensayos clnicos patrocinados por Abbvie, Almirall, Amgen, Boehringer Ingelheim, Bristol-Meyers Squibb, Celgene, Gebro, Isdin, Janssen, LEO Pharma, Lilly, Merck Serono, MSD, Novartis, Pfizer, Roche, Sandoz, Sanofi y UCB
Yarmolinsky and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
MMP metalloproteinase the VEGFR2-blocking, human anti-VEGF antibody of the invention may also be derivatized to introduce functional groups permitting the attachment of the therapeutic agent(s) through a biologically releasable bond
So far, berberine can be administered only via the oral route